|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Rights Issue (Via Preemptive Right)
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Other Aspects To Be Notified
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Additional Explanations
|
||||||||||||||||||||||
|
Our capital increase application which is regarding the issuance of shares with a nominal value of TRY 108,800,000 due to the increase in our Company's issued capital from TRY 136,000,000 to TRY 244,800,000 within the registered capital ceiling of TRY 250,000,000, with TRY 108,800,000 in cash, was approved by the Capital Markets Board at its 20.12.2024 dated meeting and it was published in the CMB Bulletin dated 20.12.2024 and numbered 2024/57
This statement was translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.
|
||||||||||||||||||||||